MedPath

Icosapent Ethyl

Generic Name
Icosapent Ethyl
Brand Names
Vascepa, Vazkepa
Drug Type
Small Molecule
Chemical Formula
C22H34O2
CAS Number
86227-47-6
Unique Ingredient Identifier
6GC8A4PAYH

Overview

Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as an adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL) and to reduce the risk of cardiovascular events in certain patients with elevated triglycerides. FDA approved on July 26, 2012.

Background

Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as an adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL) and to reduce the risk of cardiovascular events in certain patients with elevated triglycerides. FDA approved on July 26, 2012.

Indication

作为最大耐受他汀类药物治疗的辅助手段,以降低甘油三酯(TG)水平升高(≥150mg/dL)、已确定的心血管疾病或糖尿病以及2个或更多心血管疾病风险因素的成年患者需要住院治疗的心肌梗死、中风、冠状动脉血运重建和不稳定心绞痛的风险。

Associated Conditions

  • Hospitalizations
  • Severe Hypertriglyceridemias

FDA Approved Products

Icosapent Ethyl
Manufacturer:Teva Pharmaceuticals, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/08/31
NDC:0480-0126
ICOSAPENT ETHYL
Manufacturer:XLCare Pharmaceuticals, Inc.
Route:ORAL
Strength:1 g in 1 1
Approved: 2024/03/15
NDC:72865-290
ICOSAPENT ETHYL
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:0.5 g in 1 1
Approved: 2023/07/09
NDC:31722-298
Icosapent Ethyl
Manufacturer:Apotex Corp
Route:ORAL
Strength:1 g in 1 1
Approved: 2023/12/14
NDC:60505-4033
ICOSAPENT ETHYL
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:1 g in 1 1
Approved: 2023/07/09
NDC:31722-299

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath